Patents by Inventor Chenli Qiu

Chenli Qiu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for amplifying CD8+T cells and cell subpopulations thereof in-vitro
    Patent number: 11773373
    Abstract: Disclosed is a method for rapidly amplifying CD8+T cells and functional cell subpopulations thereof in vitro. A TLR1/2 agonist, a TLR2/6 agonist and a TLR5 agonist or a combination of above agonists is added to a conventional culture system for in-vitro amplification of CD8+T cells. Recombinant cytokines IL-2, IL-7 and IL-15 as well as magnetic beads coated with an anti-human CD3 antibody and an anti-human CD28 antibody can be further added to the culture system for continuous co-stimulation.
    Type: Grant
    Filed: December 15, 2017
    Date of Patent: October 3, 2023
    Assignee: Shanghai Innovative Chang'An Biological Technology Co., Ltd.
    Inventors: Jianqing Xu, Xiaoyan Zhang, Chenli Qiu
  • METHOD FOR AMPLIFYING CD8+T CELLS AND CELL SUBPOPULATIONS THEREOF IN-VITRO
    Publication number: 20200063103
    Abstract: Disclosed is a method for rapidly amplifying CD8+ T cells and functional cell subpopulations thereof in vitro. A TLR1/2 agonist, a TLR2/6 agonist and a TLR5 agonist or a combination of above agonists is added to a conventional culture system for in-vitro amplification of CD8+ T cells. Recombinant cytokines IL-2, IL-7 and IL-15 as well as magnetic beads coated with an anti-human CD3 antibody and an anti-human CD28 antibody can be further added to the culture system for continuous co-stimulation.
    Type: Application
    Filed: December 15, 2017
    Publication date: February 27, 2020
    Inventors: Jianqing Xu, Xiaoyan Zhang, Chenli Qiu